This nearly 16-fold increase highlights the pivotal role of CD4+ TEMs in DCM immunopathology, highlighting their crucial role in DCM inflammation and disease progression through sustaining myocardial inflammation, tissue fibrosis, cardiac damage, and dysfunction. This evidence concerns the gene CD4 and familial dilated cardiomyopathy.